High Fidelity Restriction Endonucleases
US-2024352437-A1 · Oct 24, 2024 · US
US2016194618A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016194618-A1 |
| Application number | US-201414904840-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 10, 2014 |
| Priority date | Jul 25, 2013 |
| Publication date | Jul 7, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Polypeptides having phytase activity and polynucleotide sequences encoding the phytases are provided. The gene expresses the phytase at a level of at least 7 g/l to 40 g/L. The phytases have higher specific activity, retain activity at low pH, retain activity at high temperature, increased phosphorous equivalency, increased phosphorous bioavailability, and increased phosphorous hydrolysis. The phytases can be used in a variety of industries including food, feed, ethanol production, pharmaceuticals, and cleaning.
Opening claim text (preview).
1 . A phytase having increased phosphorous equivalency when compared to a fungal, E. coli , or a modified E. coli phytase. 2 . The phytase of claim 1 , wherein the phytase has a phosphorous equivalency in a range from 0.11 to 0.23%. 3 . A phytase having increased phosphorous bioavailability when compared to a fungal, E. coli , or modified E. coli phytase. 4 . The phytase of claim 3 , wherein the phytase has at least 60 to 65% more phosphorous bioavailability when compared to a fungal or E. coli phytase. 5 . The phytase of claim 3 , wherein the phytase has least 20 to 30% more phosphorous bioavailability when compared to a modified E. coli phytase. 6 . A phytase capable of increased phosphorous hydrolysis when compared to a fungal, E. coli , or modified E. coli phytase. 7 . The phytase of claim 6 , wherein the phytase hydrolyzes up to 90% of phosphorous from a feed comprising phytic acid. 8 . A phytase capable of hydrolyzing up to 90% of phosphorous from a feed comprising phytic acid. 9 . A phytase having at least 100% activity for more than 5 minutes at low pH. 10 . A phytase having improved activity at phytic acid concentrations from 0.2 mM to 5.1 mM of phytic acid. 11 . A phytase having a melting temperature greater than about 90 degrees C. 12 . A phytase having at least 90% activity at 2.5 minutes. 13 . A phytase that hydrolyzes anti-nutritive phytase IP2, IP3, IP4, IP5, and IP6 from a range of about 91% to about 98%.
acting on ester bonds (3.1) · CPC title
3-Phytase (3.1.3.8) · CPC title
Biofuels, e.g. bio-diesel · CPC title
for poultry · CPC title
Enzymes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.